Luana de Oliveira Leite*

Department of Life Sciences, State University of Bahia, Brazil

*Corresponding Author: Luana de Oliveira Leite, Department of Life Sciences, State University of Bahia, Brazil.

Received: July 25, 2023; Published: August 01, 2023

Abstract

Coronaviruses cause respiratory and intestinal infections in humans and animals; the majority of coronavirus infections in humans are caused by species of low pathogenicity, leading to the development of symptoms of the common cold, however, they can eventually lead to serious infections in risk groups. COVID-19 (coronavirus disease 2019) is the infectious disease caused by the new coronavirus (2019-nCoV), which at first was temporarily named 2019-nCoV and subsequently received the name SARS-CoV-2.

References

1. Ministério da Saúde. “Protocolo de Manejo Clínico para o Novo Coronavírus (2019-nCoV)”. Brasília: Ministério da Saúde (2020).
2. Centers for Disease Control and Prevention. “Interim Infection Prevention and Control Recommendations for Patients with Known or Patients Under Investigation for 2019”. Novel Coronavirus (2019-nCoV) in a Healthcare Setting (2020).
3. World Health Organization. Coronavirus disease (COVID19) Pandemic. Geneva: World Health Organization (2020).
4. World Health Organization. Novel Coronavirus (2019-nCoV) “technical guidance” (2020).
5. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected. Interim guidance (2020).
6. Martindale R., et al. “Nutrition Therapy in the patients with COVID-19 Disease Requiring ICU care. Society of Critical Care Medicine; American Society for Parenteral and Enteral Nutrition (ASPEN) 44.7 (2020): 1174-1184.
7. Laviano A., et al. “Nutrition support in the time of SARS-CoV-2 (COVID-19)”. Nutrition (2020):110834.
8. Caccialanza R., et al. “Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol”. Nutrition (2020): 110835.
9. Barazzoni R., et al. “ESPEN expert statements and practical guidance for nutritional management of individuals with SARSCoV-2 infection”. Clinical Nutrition (2020).
10. Jin YH., et al. “A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)”. Military Medical Research 7 (2020): 4.
11. Zhang L and Liu Y. “Potential interventions for novel coronavirus in China: a systematic review”. Journal of Medical Virology 92 (2020): 479-490.
12. Singer P., et al. “ESPEN guideline on clinical nutrition in the intensive care unit”. Clinical Nutrition 1 (2019): 48-79.
13. McClave SA., et al. “Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)”. JPEN Journal of Parenteral and Enteral Nutrition 2 (2016): 159‐211.
14. Campos LF., et al. “Parecer BRASPEN/AMIB para o enfrentamento do COVID-19 em pacientes hospitalizados”. BRASPENJ1 (2013): 3-5.
15. da Silva JSV., et al. “ASPEN Consensus Recommendations for Refeeding Syndrome”. Nutrition in Clinical Practice 2 (2020): 178-195.
16. National Health Commission of the People’s Republic of China. Chinese management guideline for COVID-19 (version 7.0) (2020).

Citation

Citation: Luana de Oliveira Leite. “What are the Main Aspects of Nutritional Therapy for Patients Hospitalized with Covid-19?".Acta Scientific Nutritional Health 7.9 (2023): 01-02.

Copyright

Copyright: © 2023 Luana de Oliveira Leite. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.